Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Puberty-Associated Emergence of Hypertrophic Cardiomyopathy: When Genetics Meets Growth.

JACC. Case reports·2026

Same author

The prognostic role of pre-treatment global longitudinal strain in patients treated with Immune Checkpoint Inhibitors.

European heart journal. Cardiovascular Imaging·2026

Same author

Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY Study.

Cancer medicine·2026

Same author

QT interval changes in transgender/gender diverse adolescents receiving gonadotropin-releasing hormone agonist and gender-affirming hormonal treatment.

International journal of transgender health·2026

Same author

A novel mitochondrial <i>ATP8</i> gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy.

BMJ case reports·2025

Same author

IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel.

JACC. CardioOncology·2025

Same journal

Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?

Cardiology in the young·2026

Same journal

Emotional intelligence: An added metric of neurodevelopment in a CHD cohort.

Cardiology in the young·2026

Same journal

Case-based learning in paediatric cardiology training.

Cardiology in the young·2026

Same journal

A scoping review of the evidence supporting antiarrhythmic use after paediatric cardiac surgery.

Cardiology in the young·2026

Same journal

Dexrazoxane in children receiving anthracyclines: efficacy, safety, and region-specific considerations for Latin America.

Cardiology in the young·2026

Same journal

Evaluation of clinical, laboratory, and epidemiological features of children with Kawasaki disease.

Cardiology in the young·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 6, 2026

A Novel Ex Ovo Banding Technique to Alter Intracardiac Hemodynamics in an Embryonic Chicken System

A Novel Ex Ovo Banding Technique to Alter Intracardiac Hemodynamics in an Embryonic Chicken System

Published on: May 13, 2016

Dealing with Ebstein's anomaly.

Lianne M Geerdink¹, Livia Kapusta²

¹1 Department of Pediatrics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Cardiology in the Young

|October 31, 2013

Summary

This summary is machine-generated.

Ebstein's anomaly, a congenital heart defect, presents with varied severity in children. This review details its natural history, diagnosis, and surgical options to improve patient outcomes.

More Related Videos

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on: December 16, 2022

Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation

Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation

Published on: February 29, 2020

Related Experiment Videos

Last Updated: May 6, 2026

A Novel Ex Ovo Banding Technique to Alter Intracardiac Hemodynamics in an Embryonic Chicken System

A Novel Ex Ovo Banding Technique to Alter Intracardiac Hemodynamics in an Embryonic Chicken System

Published on: May 13, 2016

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on: December 16, 2022

Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation

Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation

Published on: February 29, 2020

Area of Science:

Pediatric Cardiology
Congenital Heart Disease
Cardiac Surgery

Background:

Ebstein's anomaly is a rare congenital heart defect affecting the tricuspid valve.
It presents with a wide spectrum of clinical severity, necessitating individualized treatment approaches.
Neonatal and early childhood presentations are common.

Purpose of the Study:

To review the natural history of Ebstein's anomaly in pediatric patients.
To discuss current classification, diagnostic methods, and surgical interventions.
To emphasize patient-tailored treatment for improved quality and duration of life.

Main Methods:

Literature review focusing on pediatric Ebstein's anomaly.
Analysis of natural history, diagnostic modalities, and surgical strategies.
Synthesis of information for clinical decision-making.

Main Results:

Ebstein's anomaly exhibits diverse clinical presentations and requires tailored management.
Diagnostic tools aid in assessing disease severity and surgical timing.
Surgical options range from neonatal interventions to later-stage procedures.

Conclusions:

A comprehensive understanding of Ebstein's anomaly is crucial for effective patient management.
Individualized treatment plans, informed by diagnostic assessments, are key.
Optimizing surgical timing and approach improves long-term outcomes for affected children.